Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients.
Avenoso D, Mehra V, Slonim LB, de Farias M, Alshehri H, Bouziana S, Krishnamurthy P, Kulasekararaj A, Dazzi F, Wood H, Kenyon M, Leung YT, Anteh S, Shah MN, Hannah G, Serpenti F, Gameil A, Bourlon C, Dragoi OD, Pagliuca A, Potter V.
Avenoso D, et al. Among authors: leung yt.
Transplant Cell Ther. 2023 Nov;29(11):698.e1-698.e6. doi: 10.1016/j.jtct.2023.08.012. Epub 2023 Aug 12.
Transplant Cell Ther. 2023.
PMID: 37579918
Free article.